Allergan’s migraine tablet Ubrelvy (ubrogepant) has been approved in the US for the acute treatment of patients with or without aura.

Allergan And Perrigo Announce First-To-Market Launch Of Store Brand Equivalent To Mucinex® D 600mg ER Tablets DUBLIN, Jan. 4, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) and its partner Perrigo ...

Allergan sells 30 capsules of its Alzheimer’s drug Namenda XR for about $440, according to the price-comparison site GoodRX. ... Twice as many tablets of the generic, ...

Allergan's shares have risen 16.9% in the period compared with a 7.8% increase for the industry. In February, the FDA delayed the action date for ulipristal acetate by three months from May to August.

Allergan brought in $4 billion in net revenue in the third-quarter this year. ... Ubrelvy, which comes in tablet form, can be effective in treating migraines with aura, ...

Oct. 3, 2005--Allergan, Inc. ... launching as an injection in 1993 and a tablet formulation in 1995. IMITREX(R) has treated more than 764 million migraine attacks worldwide, ...

Some U.S. women given a sample package of an Allergan birth control drug got more than they bargained for: ... Last year, Endo’s Par recalled 162 lots, comprising 1,365,559 tablets, ...

Allergan, Perrigo introduce store brand equivalent to Mucinex D 600mg ER tablets: Dublin, Ireland Tuesday, January 5, 2016, 16:00 Hrs [IST] Allergan plc, a global pharmaceutical company, and its ...

March 23 (Reuters) - Allergan Plc. March 23 (Reuters) - Allergan Plc. Skip to main content. Exclusive news, data and analytics for financial market professionals Learn more about Refinitiv.